ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population

ArticleAçık Erişim

Özet

The purpose of this study was to determine differences in genotype distribution and allele frequency of urokinase and vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) between first-stone formers, recurrent stone formers, and controls in a Caucasian population. A total of 86 first-stone formers, 78 recurrent stone formers, and 167 controls were included. Urokinase and VDR SNPs were tested by gene amplification followed by ApaL1 and Taq1 endonuclease digestion, respectively. Baseline variables, genotype, and allele frequencies were compared between the three groups, using descriptive statistics. Adjusted odds ratios were calculated to estimate the risk for recurrent urolithiasis associated with genotypes. We found that differences in the distribution of ApaL1 SNP and Taq1 SNP genotypes were statistically different between recurrent stone formers and first-stone formers, and between recurrent stone formers and controls. Allele frequency analysis showed that the T allele for ApaL1 SNP and the C allele for Taq1 SNP were significantly associated with recurrent urolithiasis. For Taq1 SNP, logistic regression analysis showed that the C/C genotype was associated with a more than threefold higher risk for recurrent urolithiasis. We conclude that ApaL1 and Taq1 SNPs of the urokinase and VDR genes are associated with recurrent urolithiasis in a Caucasian population. © 2015, Springer-Verlag Berlin Heidelberg.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15339Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s00240-015-0813-1Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAykan, Serdar
dc.contributor.authorTuken, Murat
dc.contributor.authorGunes, Sezgin
dc.contributor.authorAkin, Yigit
dc.contributor.authorOzturk, Murat
dc.contributor.authorSeyhan, Serkan
dc.contributor.authorYuruk, Emrah
dc.contributor.authorTemiz, Mustafa Zafer
dc.contributor.authorYılmaz, Ali Faik
dc.contributor.authorNguyen, Daniel P.
dc.date.accessioned2026-10-18T20:30:09.356377994Z
dc.date.available2026-10-18T20:30:09.356377994Z
dc.date.issued2016
dc.description.abstractThe purpose of this study was to determine differences in genotype distribution and allele frequency of urokinase and vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) between first-stone formers, recurrent stone formers, and controls in a Caucasian population. A total of 86 first-stone formers, 78 recurrent stone formers, and 167 controls were included. Urokinase and VDR SNPs were tested by gene amplification followed by ApaL1 and Taq1 endonuclease digestion, respectively. Baseline variables, genotype, and allele frequencies were compared between the three groups, using descriptive statistics. Adjusted odds ratios were calculated to estimate the risk for recurrent urolithiasis associated with genotypes. We found that differences in the distribution of ApaL1 SNP and Taq1 SNP genotypes were statistically different between recurrent stone formers and first-stone formers, and between recurrent stone formers and controls. Allele frequency analysis showed that the T allele for ApaL1 SNP and the C allele for Taq1 SNP were significantly associated with recurrent urolithiasis. For Taq1 SNP, logistic regression analysis showed that the C/C genotype was associated with a more than threefold higher risk for recurrent urolithiasis. We conclude that ApaL1 and Taq1 SNPs of the urokinase and VDR genes are associated with recurrent urolithiasis in a Caucasian population. © 2015, Springer-Verlag Berlin Heidelberg.
dc.identifier.doi10.1007/s00240-015-0813-1
dc.identifier.eissn2194-7236
dc.identifier.endpage115
dc.identifier.issn2194-7228
dc.identifier.issue2
dc.identifier.pmid26275878
dc.identifier.scopus2-s2.0-84961114043
dc.identifier.startpage109
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15339
dc.identifier.volume44
dc.identifier.wosWOS:000372750900002
dc.language.isoen
dc.publisherSpringer Verlag
dc.relation.ispartofUrolithiasis
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSingle nucleotide polymorphism
dc.subjectUrokinase
dc.subjectUrolithiasis
dc.subjectVitamin D receptor
dc.subjectAdult
dc.subjectDeoxyribonucleases, Type II Site-Specific
dc.subjectEuropean Continental Ancestry Group
dc.subjectFemale
dc.subjectGene Frequency
dc.subjectGenotype
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectOdds Ratio
dc.subjectPolymorphism, Restriction Fragment Length
dc.subjectPolymorphism, Single Nucleotide
dc.subjectReceptors, Calcitriol
dc.subjectRecurrence
dc.subjectRisk Factors
dc.subjectUrokinase-Type Plasminogen Activator
dc.subjectYoung Adult
dc.subjectcalcitriol receptor
dc.subjectTCGA-specific type II deoxyribonucleases
dc.subjecttype II site specific deoxyribonuclease
dc.subjectVDR protein, human
dc.subjectArticle
dc.subjectCaucasian
dc.subjectcontrolled study
dc.subjectgene amplification
dc.subjectgenetic association
dc.titleApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus15
rdl.citation.wos14
rdl.departmentDepartment of Urology, Erzincan University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)